Macrophage attenuation of neuronal excitability: implications for pathogenesis of neurodegenerative disorders

Wenwei Wang1, Dehui Hu, Huangui Xiong

  • 1Neurophysiology Laboratory, The Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska 68198-5880, USA.

Glia
|November 30, 2007
PubMed

Insights

Mouse bone marrow-derived macrophages (BMDMs) reduce neuronal excitability by enhancing potassium currents. This finding offers insights into neurodegenerative disease mechanisms.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Brain macrophages, including microglia, are key players in CNS immunity and inflammation.
  • These cells are implicated in the pathology of neurodegenerative diseases.

Purpose of the Study:

  • To investigate how mouse bone marrow-derived macrophages (BMDMs) affect rat cortical neuronal physiology.
  • To elucidate the mechanisms underlying macrophage-induced neuronal dysfunction.

Main Methods:

  • Utilized a co-culture system of BMDMs and rat cortical neurons.
  • Employed whole-cell patch clamp techniques to record neuronal electrical activity.

Main Results:

  • BMDMs induced neuronal membrane hyperpolarization and decreased input resistance.
  • Spontaneous and evoked neuronal firing were attenuated by BMDMs.
  • BMDMs enhanced the delayed rectifier potassium current (IK), leading to reduced neuronal excitability.

Conclusions:

  • BMDMs significantly attenuate neuronal excitability.
  • The enhancement of IK by BMDMs is a key mechanism for this effect.
  • This macrophage-induced neuronal hyperexcitability may contribute to neurodegenerative disorders.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...